Download the Protocol

HGH 191AA

HGH 191AA is a lab-made version of the body’s natural growth hormone. It helps support growth, repair, and energy balance. People study it to understand how it may improve recovery, strength, or metabolism. This compound is meant for research only, not medical use.

Description

• HGH 191AA is a recombinant form of the naturally occurring 191-amino-acid human growth hormone.
• It is bioidentical to endogenous pituitary GH and studied for its effects on cell growth, metabolism, and tissue repair.
• Research focuses on growth deficiency, recovery, and anti-aging pathways involving GH and IGF-1 signaling.

How It Works

• Binds to growth hormone receptors throughout the body, stimulating protein synthesis and lipolysis.
• Increases hepatic production of insulin-like growth factor-1 (IGF-1), which drives many anabolic effects of GH.
• Supports cellular repair, regeneration, and metabolic efficiency in tissues such as muscle, bone, and skin.

Documented Effects

• Promotes lean muscle growth and reduces body fat in GH-deficient models.
• Improves collagen synthesis, recovery time, and cellular turnover.
• Enhances bone density and immune modulation under controlled conditions.

Theoretical Effects

• Potential applications in tissue regeneration, recovery, and metabolic optimization.
• May improve sleep quality and energy levels through normalization of GH pulse rhythm.
• Long-term safety data for supra-physiologic dosing remain limited.

Pharmacokinetics

• Half-life: Approximately 2–3 hours after subcutaneous injection.
• Time to peak concentration: Reached within 3–6 hours post-injection.
• Steady-state: Typically achieved after 2–3 days of consistent dosing.

Duration of Effects

• Metabolic and regenerative effects persist for 12–24 hours post-injection.
• IGF-1 elevation may continue for up to 24–36 hours after dosing.
• Benefits such as improved recovery and skin health build gradually and fade slowly after discontinuation.

Reconstitution

• Use only bacteriostatic water to reconstitute the lyophilized powder.
• Example vial: 10 IU of HGH 191AA
• Choose reconstitution volume based on dosing convenience:
  • 1 mL water → 10 IU/mL → 1 IU per 10 units (0.1 mL)
  • 2 mL water → 5 IU/mL → 0.5 IU per 10 units
• Example: To make each 10 units equal 1 IU, add 1 mL of bacteriostatic water to the 10 IU vial.
• Swirl gently to dissolve; do not shake.
• Refrigerate reconstituted solution (2–8 °C). Use within ~14 days for best stability.

Injectable Dosage Overview (Research Reference)

Typical Starting Dose

• Injectable (research use): 1–2 IU subcutaneous (SC) once daily.
• Conservative initiation: 1 IU daily to monitor tolerance and IGF-1 response.

Common Research Range

• Typical range: 1–4 IU SC daily, often split into morning and pre-sleep injections.
• Protocols may combine with IGF-1 analogs or GHRPs for synergistic anabolic response.

Maximum Research Range

• Anecdotal ceiling: 6–8 IU daily in intensive recovery or anti-aging studies.
• Higher doses increase risk of fluid retention and insulin resistance.

Standard Cycle Length

• Research cycles typically last 3–6 months for regenerative outcomes.
• Breaks of 4–8 weeks are advised between extended cycles to assess baseline recovery.

Clinical Notes

• Injected subcutaneously using insulin syringes; rotate sites to prevent irritation.
• Tapering is optional but may help maintain balance after prolonged use.
• Stacking with GHRPs or IGF analogs should be done cautiously to avoid excessive IGF-1 levels.
• Stable for about 14 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing.

Safety Notes (First-Time Use)

• Possible mild edema, joint stiffness, or tingling from fluid redistribution.
• Monitor fasting glucose and IGF-1 levels if used in extended studies.
• Research-only compound; not approved for therapeutic or cosmetic use.